Mechanism of Jianpi Bushen Yiqi Decoction in promoting AChR clustering and improving neuromuscular junction function in EAMG mice based on Agrin/LRP4/MuSK signaling pathway.
10.19540/j.cnki.cjcmm.20250409.403
- Author:
Jia-Hui WANG
1
;
Ru-Ge LIU
1
;
Han-Bin LIU
1
;
Jia-Hao WEI
1
;
Jie ZHANG
1
;
Xue-Ying LIU
1
;
Feng GAO
2
;
Jun-Hong YANG
3
Author Information
1. the First Clinical Medical College of Henan University of Chinese Medicine Zhengzhou 450046, China.
2. Henan Institute of Medical and Pharmaceutical Sciences of Zhengzhou University Zhengzhou 450052, China.
3. the First Affiliated Hospital of Henan University of Chinese Medicine Zhengzhou 450000, China.
- Publication Type:Journal Article
- Keywords:
AChR cluster;
Agrin/LRP4/MuSK signaling pathway;
Jianpi Bushen Yiqi Decoction;
myasthenia gravis;
neuromuscular junction
- MeSH:
Animals;
Agrin/genetics*;
Mice;
Drugs, Chinese Herbal/administration & dosage*;
Signal Transduction/drug effects*;
Receptors, Cholinergic/genetics*;
Female;
Mice, Inbred C57BL;
Receptor Protein-Tyrosine Kinases/genetics*;
Neuromuscular Junction/metabolism*;
Myasthenia Gravis, Autoimmune, Experimental/physiopathology*;
Humans;
LDL-Receptor Related Proteins
- From:
China Journal of Chinese Materia Medica
2025;50(15):4325-4332
- CountryChina
- Language:Chinese
-
Abstract:
This study investigated the mechanism by which Jianpi Bushen Yiqi Decoction promotes acetylcholine receptor(AChR) clustering in myasthenia gravis through the Agrin/low-density lipoprotein receptor-related protein 4(LRP4)/muscle-specific receptor tyrosine kinases(MuSK) signaling pathway. A total of 114 female C57BL/6J mice were divided into the normal group, modeling group, and solvent control group. The normal group and the solvent control group were immunized with phosphate-buffered saline(PBS), while the modeling group was established as an experimental autoimmune myasthenia gravis(EAMG) model using the murine-derived AChR-α subunit R97-116 peptide fragment. After successful modeling, the mice were randomly assigned to the model group, the low-, medium-, and high-dose Jianpi Bushen Yiqi Decoction groups, and the prednisone group. After four weeks of continuous treatment, muscle strength was assessed using Lennon scores and grip strength tests. Immunofluorescence staining was conducted on differentiated C2C12 myotubes incubated with a drug-containing serum to observe the number of AChR clusters. The integrity of AChR on myofilaments in mouse gastrocnemius muscles was further assessed by immunofluorescence staining. Hematoxylin-Eosin(HE)staining was applied to examine pathological changes in the gastrocnemius muscles of EAMG mice treated with Jianpi Bushen Yiqi Decoction. Western blot was utilized to detect the expression of key proteins in the Agrin/LRP4/MuSK signaling pathway in both C2C12 myotubes and mouse gastrocnemius muscles. The results demonstrated that compared to the model group, the prednisone group exhibited a significant decrease in the body weights of mice, whereas no significant differences in the body weights of mice were observed among the low-, medium-, and high-dose Jianpi Bushen Yiqi Decoction groups. All treatment groups showed significantly improved grip strength and Lennon scores. Additionally, the formula promoted AChR clustering on myotubes and enhanced AChR integrity in gastrocnemius myofilaments and reduced inflammatory infiltration between muscle tissue and fibrous hyperplasia. Furthermore, Jianpi Bushen Yiqi Decoction upregulated the protein expression of AChRα1, Agrin, and p-MuSK in C2C12 myotubes and increased the protein expression of AChRα1, Agrin, MuSK, p-MuSK, LRP4, and docking protein 7(Dok-7)in gastrocnemius tissue. In conclusion, Jianpi Bushen Yiqi Decoction may promote AChR clustering by targeting key proteins in the Agrin/LRP4/MuSK signaling pathway, thereby improving neuromuscular junction function and enhancing muscle strength.
